tradingkey.logo

Microbot Medical Inc

MBOT
View Detailed Chart
2.210USD
+0.130+6.25%
Market hours ETQuotes delayed by 15 min
145.49MMarket Cap
LossP/E TTM

Microbot Medical Inc

2.210
+0.130+6.25%
Intraday
1m
30m
1h
D
W
M
D

Today

+6.25%

5 Days

-8.30%

1 Month

+20.77%

6 Months

-8.30%

Year to Date

+97.32%

1 Year

+126.78%

View Detailed Chart

TradingKey Stock Score of Microbot Medical Inc

Currency: USD Updated: 2025-12-19

Key Insights

Microbot Medical Inc's fundamentals are relatively weak, and its growth potential is high.Its valuation is considered fairly valued, ranking 152/404 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 8.75.In the medium term, the stock price is expected to trend down.Despite a good stock market performance and strong technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Microbot Medical Inc's Score

Industry at a Glance

Industry Ranking
152 / 404
Overall Ranking
280 / 4582
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 2 analysts
Buy
Current Rating
8.750
Target Price
+270.76%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Microbot Medical Inc Highlights

StrengthsRisks
Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
Undervalued
The company’s latest PE is -4.62, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 5.08M shares, decreasing 15.14% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 2.34M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.02.

Microbot Medical Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Microbot Medical Inc Info

Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
Ticker SymbolMBOT
CompanyMicrobot Medical Inc
CEOGadot (Harel)
Websitehttp://www.microbotmedical.com/

FAQs

What is the current price of Microbot Medical Inc (MBOT)?

The current price of Microbot Medical Inc (MBOT) is 2.210.

What is the symbol of Microbot Medical Inc?

The ticker symbol of Microbot Medical Inc is MBOT.

What is the 52-week high of Microbot Medical Inc?

The 52-week high of Microbot Medical Inc is 4.670.

What is the 52-week low of Microbot Medical Inc?

The 52-week low of Microbot Medical Inc is 0.960.

What is the market capitalization of Microbot Medical Inc?

The market capitalization of Microbot Medical Inc is 145.49M.

What is the net income of Microbot Medical Inc?

The net income of Microbot Medical Inc is -11.44M.

Is Microbot Medical Inc (MBOT) currently rated as Buy, Hold, or Sell?

According to analysts, Microbot Medical Inc (MBOT) has an overall rating of Buy, with a price target of 8.750.

What is the Earnings Per Share (EPS TTM) of Microbot Medical Inc (MBOT)?

The Earnings Per Share (EPS TTM) of Microbot Medical Inc (MBOT) is -0.450.
KeyAI